Glendon E. French III, Director at Pulmonx Corp (LUNG), sold 20,000 shares at $8.09 ($162K) on 2024-09-12, disclosed to the SEC on 2024-09-18.
Scheduled sale ($162k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| LUNG | SELL | 2026-03-04 | $97K | — | Filing → |
| LUNG | SELL | 2025-12-03 | $14K | — | Filing → |
| LUNG | SELL | 2025-03-21 | $157K | — | Filing → |